- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03402009
Comparison of Mindfulness Meditation Tools For College Students
Assisting University Students Self-Manage Stress: Comparison of Mindfulness Meditation Tools
Study Overview
Status
Intervention / Treatment
Detailed Description
Investigators will conduct a randomized controlled trial to evaluate strategies for assisting students develop a personal meditation practice. All participants will attend a mindfulness orientation, then begin the four-week intervention. During the intervention period, the treatment group will practice EEG-neurofeedback-assisted meditation using the Muse device (Interaxon) at least eight times over the four-week intervention period, and also practice mindfulness meditation on their own using their choice of tools (e.g., apps, weblinks, breath). The active control group will mirror the treatment group but will not have access to the EEG-neurofeedback device.
After a sufficient number of students register for the study who meet eligibility requirements, they will be provided with an option to enroll online in the first wave of the study, if their schedule allows, or be placed on a waitlist. Subsequent waves will take place throughout the semester(s) to accommodate additional participants. Enrolled participants will be asked to complete the pre-workshop questionnaire packet online, and attend an orientation session. During the orientation session, participants will first sign a consent form, provide a baseline saliva sample, then learn the basic technique of mindfulness meditation with an experienced meditation instructor. The orientation will also briefly explain the potential benefits of meditation from a scientific perspective, and emphasize the importance of establishing a daily practice, with the mindset that even one minute counts. Participants will then be asked to meditate for 3 minutes wearing the EEG device in order to get a baseline EEG reading. Following the orientation workshop, participants will be randomly assigned and notified via email into either the active control or treatment group along with group-specific instructions, and the 4-week intervention period will commence. Upon completion of the 4-week intervention, participants will be asked to complete post-intervention questionnaires online, then provide post-test measures of saliva, EEG reading during a 3 minute meditation. Participants will be debriefed, and those in the active control group will be given the option to use the EEG-neurofeedback. Follow-up surveys will be emailed to participants at 3, 6 and 12 months to examine if participants continue their meditation practice.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Connecticut
-
Storrs, Connecticut, United States, 06269
- University of Connecticut
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- English literate, undergraduates and graduate students attending UConn ages 18 and above (unless they are registered with the participant pool), who agree with the initial terms, are willing to learn basic skills of mindfulness meditation, agree to practice meditating with assigned tools independently and feel able to adhere to the time commitment required for the study. Participants must not currently have a regular seated meditation practice (regular, meaning at least 1x per week).
Exclusion Criteria:
- participants unable to adhere to the commitment required for the study will be excluded
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental
independent meditation using web-based tools, apps, and EEG neurofeedback
|
Apps and weblinks to coach self-guided meditation.
Device provides feedback based on EEG readings.
|
Active Comparator: Active Control
independent meditation using web-based tools and apps
|
Apps and weblinks to coach self-guided meditation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Depression, Anxiety, and Stress Scales-21
Time Frame: 5 weeks
|
(DASS-21; Lovibond & Lovibond, 1995): an abbreviated, 21-item, Likert-style scale to assess levels of distress on three subscales: depression, anxiety and stress, based on how one felt over the past week.
The DASS-21 has been used in prior studies assessing the benefits of mindfulness in undergraduate students (Gallego et al., 2014).
It consists of 21 items with seven items per subscale, scored on a four-point scale ranging from 0 = did not apply to me at all to 3 = applied to me very much or most of the time.
The total score sums all items.
Higher scores indicate higher levels of distress.
|
5 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Big Five personality
Time Frame: Baseline and 5 weeks
|
Big Five personality traits (Costa & McCrae, 1992), which are openness, conscientiousness, extraversion, agreeableness, and neuroticism.
These factors have been used to understand the relationship between personality and various academic behaviors.
Respondents rate each item on a five-point scale from "strongly disagree" to "strongly agree."
This scale been used extensively in psychology research and has demonstrated good internal consistency, test-retest reliability, and validity (Costa & McCrae, 1992).
|
Baseline and 5 weeks
|
Pittsburgh Sleep Quality Index
Time Frame: Baseline and 5 weeks
|
Sleep quality will be assessed using the The Pittsburgh Sleep Quality Index (PSQI) (Buysse et al, 1989), a commonly used, validated and reliable measure of sleep quality.
|
Baseline and 5 weeks
|
Self-Regulation of Eating Scale
Time Frame: Baseline and 5 weeks
|
The Self-Regulation of Eating Behavior Questionnaire (SREBQ) is a short, Likert format questionnaire comprising of two dichotomous screener questions, one directional question to bring tempting foods to mind, and five Likert-format items assessing respondents' self-regulation of eating.
The five Likert-format items span a five-point scale from 'Never' to 'Always'.
The SREBQ has been shown to be reliable and valid (Kliemann et al., 2016).
|
Baseline and 5 weeks
|
MINDSENS (mindfulness)
Time Frame: Baseline and 5 weeks
|
a composite index consisting of selected items from two other mindfulness questionnaires (The Five Facet Mindfulness Questionnaire and Experiences Questionnaire) that showed the strongest response to practice.
|
Baseline and 5 weeks
|
Multidimensional Assessment of Interoceptive Awareness (MAIA)
Time Frame: Baseline and 5 weeks
|
Interoceptive self-awareness.
Interoception refers to the signaling and perception of internal bodily sensations, which we will assess using the validated Multidimensional Assessment of Interoceptive Awareness (MAIA) (Mehling et.
al., 2009 and 2012).
The MAIA is a relatively new scale, with good validity and reliability in studies to date (Mehling et.
al., 2009 and 2012; Bornemann et.
Al., 2014).
|
Baseline and 5 weeks
|
Emotion Regulation Questionnaire (ERQ)
Time Frame: Baseline and 5 weeks
|
) (Gross & John, 2003).
The ERQ assesses two specific emotion regulation strategies, suppression and reappraisal.
The ERQ comprises 10 items (5 for suppression and 5 for reappraisal) rated from 1 (never do this) to 7 (always do this).
The ERQ has demonstrated strong psychometric properties (Spaapen et al., 2014).
|
Baseline and 5 weeks
|
Experiences Questionnaire (decentering)
Time Frame: Baseline and 5 weeks
|
Decentering, a specific component of mindfulness related to learning how to separate from one's own thoughts and emotions, will be assessed with the Experiences Questionnaire (Fresco 2007).
|
Baseline and 5 weeks
|
Rosenberg (1965) self-esteem scale (RSES)
Time Frame: Baseline and 5 weeks
|
a self-esteem measure widely used in social-science research, with a scale of 0 (low) to 30 (high).
It is a ten-item Likert-type scale with items answered on a four-point scale-from strongly agree to strongly disagree.
It has been used extensively in research and has demonstrated good internal consistency, test-retest reliability, and validity.
|
Baseline and 5 weeks
|
Inflammatory cytokines (i.e., C-reactive protein, IL-6, and TNF-α)
Time Frame: Baseline and 5 weeks
|
Saliva samples will be obtained in-person, during pre- and post- assessments.
Saliva samples will be stored for analysis to be performed at a later date, pending funding.
Future analysis on saliva will be limited to assays on stress and health-related biomarkers and inflammatory cytokines (i.e., C-reactive protein, IL-6, and TNF-α).
The "passive drool" method will be used to collect saliva samples, as described in Walsh et al., 2016.
|
Baseline and 5 weeks
|
State-Trait Anxiety Inventory (STAI)
Time Frame: Baseline and 5 weeks
|
Inventory aimed to measure one's awareness of their levels of both state and trait anxiety.
|
Baseline and 5 weeks
|
Connor-Davidson Resilience Scale (CD-RISC; Connor & Davidson, 2003)
Time Frame: Baseline and 5 weeks
|
The CD-RISC is a 25-item scale that measures the ability to cope with stress and adversity.
Items include: "I am able to adapt when changes occur," "I tend to bounce back after illness, injury, or other hardships," and "I am able to handle unpleasant or painful feelings like sadness, fear, and anger."
Respondents rate items on a scale from 0 ("not true at all") to 4 ("true nearly all the time").
A preliminary study of the psychometric properties of the CD-RISC in general population and patient samples showed it to have adequate internal consistency, test-retest reliability, and convergent and divergent validity (Connor & Davidson, 2003).
This measure has been used in studies that assess resilience across the lifespan (Campbell-Sills et al., 2006).
|
Baseline and 5 weeks
|
Perceived Stress Scale-4 (PSS4)
Time Frame: Baseline and 5 weeks
|
(PSS4) is an abbreviated, 4-item Likert format scale designed to measure the degree to which situations in one's life are appraised as stressful (Cohen et al., 1983).
The PSS is a validated, publicly available, and widely used psychological instrument for measuring stress.
Each item asks the participant to appraise his or her feelings and thoughts using a 5-point Likert scale (0 = never, 4 = very often)
|
Baseline and 5 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Long-term Follow-up Survey
Time Frame: 1, 6, and 12 months following completion of the satisfaction follow-up
|
Simple 2 question survey will ask participants if they are still meditating, and if so, what tools they are using for assistance.
|
1, 6, and 12 months following completion of the satisfaction follow-up
|
Satisfaction with Mindfulness Tools
Time Frame: 5 weeks
|
After the completion of the 4-week trial, an 18-item instrument will be used to solicit participants' satisfaction with the meditation tools, as well as their feelings toward their meditation practice as a result of the intervention (i.e.,.
confidence in ability, motivation to continue, and perceived benefits).
The instrument was developed for this study and asks questions about perceived benefits of mindfulness meditation and intentions to continue practicing in the future.
|
5 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Blair T. Johnson, PhD, University of Connecticut - BOT Distinguished Professor of Psychological Sciences
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- H17-224
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- Study Protocol
- Informed Consent Form (ICF)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
University of California, Los AngelesUniversity of California, San Francisco; Stanford University; California Initiative...Enrolling by invitationStress | Stress, Psychological | Stress, Emotional | Stress, Physiological | Stress ReactionUnited States
-
University of PadovaRecruitingStress | Stress Disorder | Work Related StressItaly
-
Dana-Farber Cancer InstituteEnrolling by invitationStress | Post Traumatic Stress Disorder | Work Related StressUnited States
-
Duquesne UniversityUniversity of California, San Diego; West Penn Allegheny Health System; El Centro... and other collaboratorsTerminated
-
University of Sao PauloCompleted
-
Syracuse VA Medical CenterUS Department of Veterans AffairsCompletedEmotional Stress | Psychological Stress | Life StressUnited States
-
Royal Cornwall Hospitals TrustEnrolling by invitationStress | Stress, Psychological | Stress, JobUnited Kingdom
-
Northumbria UniversityVolac International LtdRecruitingStress | Mood | Physiological StressUnited Kingdom
-
Taichung Veterans General HospitalUnknown
Clinical Trials on Apps
-
Ministry of Science and Technology, TaiwanTaipei Hospital, Ministry of Health and WelfareCompleted
-
University of NottinghamUnknownMild Dementia | Moderate DementiaUnited Kingdom
-
Hong Kong Metropolitan UniversityHealth and Medical Research FundRecruitingAnxiety | Depressive Symptoms | Well-Being, PsychologicalHong Kong
-
University of California, DavisStanford University; Rutgers University; Northeastern UniversityActive, not recruiting
-
Winterlight LabsActive, not recruitingPsychiatric Disorder | Language | SpeechCanada
-
Wake Forest University Health SciencesCompletedCovid19 | Respiratory FailureUnited States
-
Ottawa Hospital Research InstituteTerminated
-
Universidad Miguel Hernandez de ElcheInstitut Català de la Salut; Andaluz Health Service; Osakidetza; Servicio Madrileño... and other collaboratorsCompletedOccupational DiseasesSpain
-
VA Office of Research and DevelopmentDurham VA Medical Center; US Department of Veterans Affairs Center for Healthcare...CompletedIntroduction of Teledermatology Mobile AppsUnited States